Philippe Edouard
About Philippe Edouard
Philippe Edouard serves as the Vice President and Head of Legal and Intellectual Property at Inozyme Pharma, where he oversees corporate and transactional legal matters. With over 20 years of experience in the life sciences industry, he has transitioned from a career as an R&D scientist to a legal expert specializing in intellectual property law.
Current Role at Inozyme
Philippe Edouard serves as the Vice President, Head of Legal and Intellectual Property at Inozyme Pharma since 2023. In this role, he has primary legal responsibility for the company's corporate and transactional matters, which include venture capital transactions and security offerings. He is a key member of the senior leadership team, contributing to the company's overarching objectives. Edouard leads the execution of Inozyme Pharma's global intellectual property strategy, combining his legal expertise with business acumen to assist senior management in addressing substantial company issues.
Previous Experience in Legal and Intellectual Property
Before joining Inozyme Pharma, Philippe Edouard held several significant positions in the legal and intellectual property sector. He worked at Visterra Inc. as Vice President, Intellectual Property and Contracts from 2022 to 2023 and previously served as Head IP Counsel from 2020 to 2022. His experience also includes a role as Senior Director of Intellectual Property at Shire from 2015 to 2020 and as Intellectual Property Counsel at Volcano Corporation from 2013 to 2014. Earlier in his career, he was an Associate at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP from 2009 to 2012 and at Brown Rudnick LLP from 2012 to 2013.
Educational Background
Philippe Edouard has an extensive educational background in law and life sciences. He earned a Doctor of Law (JD) from Boston University School of Law in 2009. He also holds a Master of Arts (MA) in Biotechnology from Boston University, achieved in 1996, and a Bachelor of Arts (BA) in Biochemistry and Molecular Biology from the same institution, completed in 1995. Additionally, he is pursuing a Master of Business Administration (MBA) at NYU Stern School of Business, which he began in 2020.
Career Transition and Industry Experience
Philippe Edouard has over 20 years of experience in the life sciences industry, where he has witnessed rapid innovation in therapeutics and intellectual property law. He transitioned from a career as an R&D scientist in the biotech sector to a legal career focused on life sciences. This unique combination of scientific knowledge and legal expertise positions him to address complex issues within the industry effectively.